Joe McCarthy from Elston and David Wilson from First Sentier run the ruler over your most-tipped growth stocks for 2025 ...

And although shares fell 35% from peak-to-trough, it became apparent that those who seek these weight-loss drugs also tend to have sleep apnea and need ongoing treatment from ResMed's products. Since ...